Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

WHF Position Statement on COVID Vaccination.

F Thienemann1,2,3, G Chakafana4, D Piñeiro5

  • 1General Medicine and Global Health (GMGH), Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, ZA.

Global Heart
|May 27, 2021
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proceedings from the Third International Post-Tuberculosis Symposium: expanding the circle.

IJTLD open·2025
Same author

Photo-induced nonvolatile rewritable ferroaxial switching.

Science (New York, N.Y.)·2025
Same author

Spin Dynamics in the Dirac U(1) Spin Liquid YbZn_{2}GaO_{5}.

Physical review letters·2025
Same author

Magnetoelastic Dynamics of the Spin Jahn-Teller Transition in CoTi_{2}O_{5}.

Physical review letters·2025
Same author

Vitamin D to enhance resolution of persistent lung inflammation after TB treatment: a pilot randomised controlled trial.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2025
Same author

Docosahexaenoic Acid Supplementation During Pregnancy and Lactation and Infant Morbidity: Findings from DHANI Trial.

Indian pediatrics·2025
Same journal

Co-Developing Strategies for Patient Engagement in Decentralized Rheumatic Heart Disease Care: Lessons from Northern Uganda.

Global heart·2026
Same journal

A Thematic Analysis of Key Informant Interviews on the Implementation Experience of the HEARTS Hypertension Program in Nigeria.

Global heart·2026
Same journal

<i>Streptococcus Pyogenes</i> and Acute Rheumatic Fever: How Strong are the Links in the Chain?

Global heart·2026
Same journal

Joint Associations of Cumulative C-Reactive Protein-Triglyceride-Glucose Index and Depression with Cardiovascular Outcomes in Middle-Aged and Older Adults: A National Prospective Cohort Study.

Global heart·2026
Same journal

Mortality Outcome Post-MI after PCI and CABG Interventions.

Global heart·2026
Same journal

The Creation of the Cardiac Society of Timor-Leste: A Major Step Forward in Timorese Cardiac Health.

Global heart·2026
See all related articles
This summary is machine-generated.

Individuals with cardiovascular disease are at high risk for severe COVID-19 outcomes. Prioritizing these individuals in national COVID-19 vaccination programs is crucial for global health system resilience.

Area of Science:

  • Public Health
  • Epidemiology
  • Vaccinology

Background:

  • The COVID-19 pandemic has strained global health systems, necessitating widespread vaccination programs.
  • Limited vaccine supply requires strategic prioritization for effective disease control.
  • Cardiovascular disease (CVD) patients represent a vulnerable population with increased risk of severe COVID-19.

Discussion:

  • This statement advocates for the prioritization of individuals with cardiovascular disease in national COVID-19 vaccination strategies.
  • Prioritizing high-risk groups like CVD patients can mitigate severe illness and reduce healthcare burdens.
  • The World Heart Federation supports the systematic and equitable distribution of COVID-19 vaccines.

Key Insights:

  • Individuals with cardiovascular disease face significantly higher risks from COVID-19 infection.
Keywords:
COVID vaccinationcardiovascular diseaseglobal health

Related Experiment Videos

  • Vaccine prioritization for CVD patients is a critical public health measure.
  • Equitable vaccine access is essential for protecting vulnerable populations globally.

    • Outlook:

    • Implementing prioritized vaccination for CVD patients can enhance pandemic response effectiveness.
    • Continued research and surveillance are needed to optimize vaccine strategies for all risk groups.
    • Global collaboration is vital for ensuring sufficient vaccine supply and equitable distribution.